[{"address1": "4902 Eisenhower Boulevard", "address2": "Suite 125", "city": "Tampa", "state": "FL", "zip": "33634", "country": "United States", "phone": "813 286 7900", "fax": "813 286 7904", "website": "https://www.oragenics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002, for the treatment of mild traumatic brain injury, a fully synthetic, non-naturally occurring neurosteroid which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The company also develops NT-CoV2-1, a SARS-CoV-2 vaccine product candidate; and Lantibiotic Products. It has a license agreement with Inspirevax Inc. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. Charles L. Pope CPA", "age": 72, "title": "Executive Chairman", "yearBorn": 1952, "fiscalYear": 2024, "totalPay": 112500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Janet  Huffman", "age": 52, "title": "Interim CEO, President, CFO, Secretary & Treasurer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 332500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Greg  Gironda", "title": "Head of Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James P. Kelly M.A., M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William Franklin Peacock IV, F.A.C.E.P., FACC, M.D.", "title": "Chief Clinical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.oragenics.com/?q=investors", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.1786, "open": 0.18, "dayLow": 0.17, "dayHigh": 0.18, "regularMarketPreviousClose": 0.1786, "regularMarketOpen": 0.18, "regularMarketDayLow": 0.17, "regularMarketDayHigh": 0.18, "payoutRatio": 0.0, "beta": 0.87, "forwardPE": -0.016203703, "volume": 211258, "regularMarketVolume": 211258, "averageVolume": 4879340, "averageVolume10days": 325040, "averageDailyVolume10Day": 325040, "bid": 0.1724, "ask": 0.1781, "bidSize": 12, "askSize": 11, "marketCap": 3758177, "fiftyTwoWeekLow": 0.16, "fiftyTwoWeekHigh": 3.43, "fiftyDayAverage": 0.25, "twoHundredDayAverage": 0.504, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3221863, "profitMargins": 0.0, "floatShares": 20952366, "sharesOutstanding": 21475300, "sharesShort": 135996, "sharesShortPriorMonth": 392595, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0063, "heldPercentInsiders": 0.13282, "heldPercentInstitutions": 0.011360001, "shortRatio": 0.38, "shortPercentOfFloat": 0.0064999997, "impliedSharesOutstanding": 21475300, "bookValue": -0.017, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -10567918, "trailingEps": -1.6, "forwardEps": -10.8, "lastSplitFactor": "1:60", "lastSplitDate": 1674432000, "enterpriseToEbitda": -0.306, "52WeekChange": -0.8301887, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 0.175, "targetHighPrice": 1.0, "targetLowPrice": 1.0, "targetMeanPrice": 1.0, "targetMedianPrice": 1.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 864840, "totalCashPerShare": 0.04, "ebitda": -10531424, "totalDebt": 328528, "quickRatio": 0.513, "currentRatio": 0.874, "returnOnAssets": -2.04983, "returnOnEquity": -7.1495, "grossProfits": -4114434, "freeCashflow": -6447050, "operatingCashflow": -8597382, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "OGEN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Oragenics, Inc.", "marketState": "CLOSED", "shortName": "Oragenics Inc.", "corporateActions": [], "exchange": "ASE", "messageBoardId": "finmb_774436", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.01568, "regularMarketPrice": 0.175, "postMarketTime": 1744934380, "regularMarketTime": 1744920000, "firstTradeDateMilliseconds": 1077719400000, "postMarketChangePercent": -1.7142807, "postMarketPrice": 0.172, "postMarketChange": -0.0029999912, "regularMarketChange": -0.0036, "regularMarketDayRange": "0.17 - 0.18", "fullExchangeName": "NYSE American", "averageDailyVolume3Month": 4879340, "fiftyTwoWeekLowChange": 0.015000001, "fiftyTwoWeekLowChangePercent": 0.09375001, "fiftyTwoWeekRange": "0.16 - 3.43", "fiftyTwoWeekHighChange": -3.255, "fiftyTwoWeekHighChangePercent": -0.9489796, "fiftyTwoWeekChangePercent": -83.01887, "dividendDate": 1516579200, "earningsTimestamp": 1741982400, "earningsTimestampStart": 1747155600, "earningsTimestampEnd": 1747674000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.6, "epsForward": -10.8, "fiftyDayAverageChange": -0.075, "fiftyDayAverageChangePercent": -0.3, "twoHundredDayAverageChange": -0.329, "twoHundredDayAverageChangePercent": -0.65277773, "priceToBook": -10.294117, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "displayName": "Oragenics", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]